about
Overview, prevention and management of chemotherapy extravasationManagement of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines.Use of allogeneic platelet gel in the management of chemotherapy extravasation injuries: a case report.Venous Access Devices: Clinical Rounds.Dermatologic manifestations of cytotoxic therapy.Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.Medication wrong route administration: a poisons center-based study.Dexrazoxane: a management option for anthracycline extravasations.Extravasation injuries: a review.Extravasation of antineoplastic agents: prevention and treatments.Management of the extravasation of anti-neoplastic agents.The management of cytotoxic chemotherapy extravasation: a systematic review of the literature to evaluate the evidence underpinning contemporary practice.Dermatological adverse events with taxane chemotherapy.Injury due to extravasation of thiopental and propofol: Risks/effects of local cooling/warming in rats.Development and Validation of New RP-HPLC Method for the Determination of Dexrazoxane.The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasation: a historical case series report.Extravasation of Noncytotoxic Drugs: A Review of the Literature.T-DM1 extravasation: first description.A Case of Metronidazole Injection Infiltration Without Sequelae.Managing cytotoxic chemotherapy extravasation: use of saline washout.Anthracycline extravasations: prevention and management.
P2860
Q26767033-05FF0A84-A5FC-4050-BC63-B3DC6BAAF7D5Q34642851-1290F943-A3AA-4893-8242-3465DE6EB57FQ35094449-56C3341A-64C0-4194-9389-0D61B424DDBAQ37559441-645B1B4D-6156-4695-A877-261408B3C7ECQ37930714-465E0AEF-8CDC-41F6-9F07-DC224D6D5287Q38081464-BD55EEEB-E1A5-43A4-92E4-844528F7E804Q38082847-861B0F8D-381E-4407-8DB5-E3C670EC8714Q38143321-263E378B-B391-4CC0-B8FA-F49971058821Q38176727-D0BAA639-FA6F-42A2-B7A2-F52BB84C7696Q38268101-1A59883F-E7DD-4F49-9CB3-377791F18A4EQ38364842-C9A0F294-3A87-4E4A-A04B-5F68220E5164Q38566768-1E897768-2A56-495B-926F-578C64286A23Q38934447-57E91255-3836-42A4-9783-46F3B3A1B74FQ41682641-9B80CE2E-FFB0-43DD-8347-C56768172947Q41886287-CE1DFBD9-480C-4EEE-82D7-5E389E9FBEC1Q46583324-256AF4CA-1DFC-4A6D-8C96-5D634C745EBEQ47886612-9846D73A-9E78-4165-878C-752382315D79Q48199783-C80012AF-3DE6-4C24-BF1B-EF8CF36E3256Q49586972-A4B33679-061A-4380-B831-20E2C67AFFB6Q50985346-DE2B7F67-CC26-492B-9F09-1E4572C34B6FQ53142406-B2933D99-B345-4602-BB63-0B6B5FEA6077
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extravasation management: clinical update.
@en
Extravasation management: clinical update.
@nl
type
label
Extravasation management: clinical update.
@en
Extravasation management: clinical update.
@nl
prefLabel
Extravasation management: clinical update.
@en
Extravasation management: clinical update.
@nl
P1476
Extravasation management: clinical update
@en
P2093
Lisa Schulmeister
P356
10.1016/J.SONCN.2010.11.010
P577
2011-02-01T00:00:00Z